e-learning
resources
Conferences
Lung Science Conference
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
PP125 – Glycogen synthase kinase-3 inhibition by CHIR99021 promotes alveolar epithelial cell proliferation and lung regeneration in acute lung injury
Raquel Fernandes, Portugal
Source:
ERS Lung Science Conference 2021
Number:
57
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Raquel Fernandes, Portugal. PP125 – Glycogen synthase kinase-3 inhibition by CHIR99021 promotes alveolar epithelial cell proliferation and lung regeneration in acute lung injury. ERS Lung Science Conference 2021
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
European Respiratory Society guideline on long term management of children with bronchopulmonary dysplasia
PP306 – Submicroscopic changes of type I alveolocytes in the early stages of experimental diabetes mellitus
Related content which might interest you:
Role of phosphatidylinositol-3-kinase (PI3K) in TGF-β-induced proliferation and differentiation of human lung fibroblasts into myofibroblasts
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011
Inhibition of glycogen synthase kinase 3beta reduces GC function in human monocytes via modulation of HDAC2 activity
Source: Annual Congress 2011 - Models of disease and drug actions
Year: 2011
Inhibition of the Arp2/3 complex inhibits lung myofibroblast differentiation in vitro and attenuates bleomycin-induced pulmonary fibrosis in mice
Source: International Congress 2019 – Extracellular matrix formation and remodelling in physiology and disease
Year: 2019
The inhibition of fas-mediated apoptosis of lung alveolar epithelial cells by cyclin dependent kinase inhibitor p21
Source: Eur Respir J 2001; 18: Suppl. 33, 358s
Year: 2001
Involvement of proteasome inhibition and p53 accumulation in epithelial apoptosis of lung injury
Source: Eur Respir J 2005; 26: Suppl. 49, 101s
Year: 2005
Induction of apoptosis in murine alveolar epithelial cells by a proteasome inhibitor
Source: Eur Respir J 2001; 18: Suppl. 33, 358s
Year: 2001
Simvastatin attenuates cigarette-smoke- induced emphysema and promotion of alveolar epithelial cell proliferation in rats
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in chronic and acute airway diseases
Year: 2010
Proteasome inhibitors modulate chemokine production in lung epithelial and monocytic cells
Source: Eur Respir J 2004; 24: 40-48
Year: 2004
Mesenchymal stem cells reduce hypoxia-induced apoptosis in alveolar epithelial cells by modulating hypoxic signaling
Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease
Year: 2015
HDAC inhibitors may regulate EMT and surfactant protein C in human alveolar epithelial cells
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
Increased alveolar concentration of nitric oxide is related to serum-induced lung fibroblast proliferation in scleroderma patients
Source: Annual Congress 2009 - Cell biology of lung disease
Year: 2009
Effect of NAPDH oxidase inhibitors on lung fibroblast proliferation in systemic sclerosis
Source: International Congress 2018 – Pulmonary fibrosis: from models to patients
Year: 2018
Co-culturing alveolar epithelial with lung micro-vascular endothelial cells attenuates hypoxia-induced alveolar leakage and inhibition of reabsorption
Source: Annual Congress 2009 - Crossing the line: alveolo-capillary barrier control in acute lung injury
Year: 2009
MAPK inhibition modulates Hsp27 phosphorylation and glutathione in lung epithelial cells
Source: Eur Respir J 2006; 28: Suppl. 50, 192s
Year: 2006
Involvement of inflammation in cadmium induced lung cell proliferation
Source: Annual Congress 2010 - Causal factors and mechanisms of outdoor air pollution and nanoparticulates
Year: 2010
COX inhibition enhances remodelling processes in human lung fibroblasts
Source: Annual Congress 2010 - Regulation of airway pharmacology
Year: 2010
Wnt5a down-regulated hypoxia-induced pulmonary arterial smooth muscle cell proliferation by inhibition of β-catenin
Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension
Year: 2010
Exogenous HSP60 stimulates airway smooth muscle cell remodeling via MAPK p38 pathway
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020
Effects of TGF-beta and budesonide on MAPK phosphorylation, IL-6/IL-11 secretion, and cell proliferation in human lung fibroblasts
Source: Eur Respir J 2006; 28: Suppl. 50, 662s
Year: 2006
Effects of oral tolerance on neuronal nitric oxidase synthase expression on bronchial epithelial cells in a model of chronic pulmonary inflammation
Source: Annual Congress 2007 - Mouse models of allergic airway inflammation
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept